Shilpa Medicare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

409.73

369.97

321.46

330.80

319.30

343.80

292.51

Other Operating Income

0.00

Total Operating income

409.73

369.97

321.46

330.80

319.30

343.80

292.51

Raw Material Cost

100.75

127.64

115.04

85.49

90.05

98.55

76.71

Purchase of Finished goods

7.14

7.36

4.16

6.29

6.64

5.92

3.10

(Increase) / Decrease In Stocks

25.43

-29.50

-39.59

12.69

-5.68

17.51

13.11

Employee Cost

83.45

83.05

81.81

70.93

73.49

76.16

72.13

Power Cost

0.00

Manufacturing Expenses

0.00

-0.01

0.00

Selling and Distribution Expenses

0.00

Other Expenses

78.66

73.14

68.40

78.67

74.16

59.66

53.94

Total Expenditure (Excl Depreciation)

295.43

261.69

229.82

254.07

238.65

257.80

218.99

Operating Profit (PBDIT) excl Other Income

114.30

108.28

91.64

76.73

80.65

86.00

73.52

Other Income

0.81

1.75

6.38

7.60

1.18

4.99

9.52

Operating Profit (PBDIT)

115.11

110.03

98.02

84.33

81.83

90.99

83.04

Interest

10.68

15.67

18.78

14.49

11.75

25.55

23.74

Exceptional Items

-12.86

0.00

-28.08

0.00

Gross Profit (PBDT)

91.57

94.36

79.24

41.76

70.08

65.44

59.30

Depreciation

30.36

29.82

28.92

28.79

28.81

28.28

27.11

Profit Before Tax

60.85

64.43

49.58

15.27

41.61

36.77

28.68

Tax

16.27

20.36

2.69

0.77

9.83

18.83

14.62

Provisions and contingencies

0.00

Profit After Tax

44.93

44.18

47.62

12.21

31.44

18.33

17.58

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

44.93

44.18

47.62

12.21

31.44

18.33

17.58

Share in Profit of Associates

-0.35

-0.11

-0.73

2.30

0.34

-0.39

-3.52

Minority Interest

0.00

0.01

0.00

Other related items

0.00

Consolidated Net Profit

44.58

44.07

46.89

14.51

31.78

17.94

14.06

Equity Capital

19.56

9.78

Face Value

1.0

Reserves

0.00

Earnings per share (EPS)

2.28

2.25

2.4

0.74

1.62

0.92

1.44

Diluted Earnings per share

2.36

2.75

2.4

0.74

1.62

0.92

1.46

Operating Profit Margin (Excl OI)

27.9%

29.27%

28.51%

23.2%

25.26%

25.01%

25.13%

Gross Profit Margin

22.35%

25.5%

24.65%

12.62%

21.95%

19.03%

20.27%

PAT Margin

10.88%

11.91%

14.59%

4.39%

9.95%

5.22%

4.81%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 10.75% vs 15.09% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 1.16% vs -6.01% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 5.56% vs 18.16% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -31.84% vs -16.56% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Shilpa Medicare With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

409.73

172.34

237.39

137.75%

Other Operating Income

0.00

Total Operating income

409.73

172.34

237.39

137.75%

Raw Material Cost

100.75

70.26

30.49

43.40%

Purchase of Finished goods

7.14

0.00

7.14

(Increase) / Decrease In Stocks

25.43

-10.07

35.50

352.53%

Employee Cost

83.45

15.04

68.41

454.85%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

78.66

37.14

41.52

111.79%

Total Expenditure (Excl Depreciation)

295.43

112.37

183.06

162.91%

Operating Profit (PBDIT) excl Other Income

114.30

59.97

54.33

90.60%

Other Income

0.81

6.84

-6.03

-88.16%

Operating Profit (PBDIT)

115.11

66.81

48.30

72.29%

Interest

10.68

1.17

9.51

812.82%

Exceptional Items

-12.86

0.00

-12.86

Gross Profit (PBDT)

91.57

65.64

25.93

39.50%

Depreciation

30.36

3.86

26.50

686.53%

Profit Before Tax

60.85

61.78

-0.93

-1.51%

Tax

16.27

14.08

2.19

15.55%

Provisions and contingencies

0.00

Profit After Tax

44.93

47.70

-2.77

-5.81%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

44.93

47.70

-2.77

-5.81%

Share in Profit of Associates

-0.35

0.00

-0.35

Minority Interest

0.00

0.24

-0.24

-100.00%

Other related items

0.00

Consolidated Net Profit

44.58

47.46

-2.88

-6.07%

Equity Capital

19.56

11.29

8.27

73.25%

Face Value

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

2.28

4.20

-1.92

-45.71%

Diluted Earnings per share

2.36

4.29

-1.93

-44.99%

Operating Profit Margin (Excl OI)

27.90%

34.80%

0.00

-6.90%

Gross Profit Margin

22.35%

38.09%

0.00

-15.74%

PAT Margin

10.88%

27.68%

0.00

-16.80%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 409.73 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 10.75% vs 15.09% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 28.32% vs 11.35% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 44.58 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 1.16% vs -6.01% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 40.28% vs 593.89% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 114.30 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 5.56% vs 18.16% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 41.72% vs 21.79% in Dec 2024

Quarterly - Interest

Interest 10.68 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -31.84% vs -16.56% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -9.11% vs -55.19% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 27.90%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024